selamat idul fitri selamat menunaikan ibadah puasa selamat menunaikan ibadah puasa selamat menunaikan ibadah puasa hari jadi kota pasuruanisra miraj hut oku selatan, hari jadi oku selatan
News, World  

Indonesia Starts to Distribute The Sinovac Covid-19 Vaccine To Natiowide 34 Provinces

JAKARTA, GESAHKITA COM–Indonesia’s Ministry of Health will carry out the distribution in parallel with testing the vaccines made by China’s Sinovac. Nationwide distribution of the Covid-19 vaccine that was developed by Chinese firm Sinovac Biotech started on Sunday, (03/01/2021).

This distribution exercise comes after Indonesian state vaccine producer Bio Farma received 1.2 million doses of the vaccine on Dec 6 and 1.8 million doses on Dec 31.

Bambang Heriyanto, the  spokesman of Bio Farma says that the distribution the Sinovac  Covid 19 vaccine to health facilities across the country’s 34-provinces on Sunday.

He also said that the storage facilities necessary for keeping the vaccine doses had been prepared.

“All (vaccine) cold chain facilities at between 2 deg C and 8 deg C are ready. Hopefully that will help ensure the quality of the vaccines that will be used for the people,” he told a press briefing Jakarta localhost/server/gkx wrote.

Mr Bambang said that Indonesia has carried out a number of national vaccination programmes in the past so infrastructure would not be an issue.

Indonesia, currently struggling to control South-east Asia’s worst coronavirus outbreak, plans to inoculate 181.5 million people aged 18 and above, or around 67 per cent of its nearly 270 million people, within 15 months.

The shots will first be given to its 1.3 million health workers. Another 17.4 million front-line workers will get vaccinated after and then 21.5 million people aged 60 and older will get the jab between January and April.

In the second phase, scheduled to run from April this year to March 2022, 63.9 million people in high-risk areas will get vaccinated, followed by the remaining 77.4 million of the targeted population.

Her speaking during the same press briefing, the Health Ministry’s Covid-19 vaccination spokesman, Dr Siti Nadia Tarmizi, said that clinical trials of the Sinovac vaccine in Turkey and Brazil delivered what she described as “quite good” results, same as the ongoing third phase of the clinical trial in Indonesia.

She is  quite optimistic that (the programme) will go in line with the schedule and her team can begin vaccinations in the second or third week of January 202.

As seen from Interim data from a late-stage trial in Turkey showed that the Covid-19 vaccine developed by Sinovac is 91.2 per cent effective, while a similar trial in Brazil revealed the shot was more than 50 per cent effective.

Indonesia’s vaccination programme is subject to approval from drug monitoring agency BPOM, which is set to grant emergency use authorisation for the Sinovac vaccine to be used.

Dr Nadia said that the programme will be carried out by around 2,500 hospitals, 13,000 health community centres, and 49 port health authorities across the country. It will be supported by about 30,000 vaccinators.

Indonesia has so far secured nearly 330 million doses from five different suppliers, including Sinovac, AstraZeneca and Novavax, with the possibility of procuring millions more from them if needed.(STN/jeli)



Tinggalkan Balasan